Clinical Trial Update: TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial update for TC-G203 in patients with GPC3-positive advanced solid tumors, including hepatocellular carcinoma, is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TC-G203

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: Solid Cancer, GPC3 Positive Hepatocellular Carcinoma | EARLY_Phase 1 | Status: RECRUITING